Kinase Inhibitors  >>  Phase 2


12»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 036912151821242730
            
            
             
berzosertib (M6620) / EMD Serono           
          
            
             
peposertib (M3814) / EMD Serono           
          
            
             
samotolisib (LY3023414) / Eli Lilly           
          
            
             
ulixertinib (BVD-523) / BioMed Valley Discoveries           
          
            
             
tuvusertib (M1774) / EMD Serono           
          
            
             
refametinib (BAY86-9766) / Bayer           
          
            
             
zimlovisertib (PF-06650833) / Pfizer           
          
            
             
temuterkib (LY3214996) / Eli Lilly           
          
            
             
Hocena (antroquinonol) / Golden Biotechnology           
          
            
             
elimusertib (BAY 1895344) / Bayer           
          
            
             
emavusertib (CA-4948) / Curis, Dr. Reddy’s           
          
            
             
GSK2982772 / GSK           
          
            
             
amcasertib (BBI-503) / Sumitomo Pharma           
          
            
             
oditrasertib (DNL788) / Denali Therap, Sanofi           
          
            
             
LP-168 / Lupeng Pharma           
          
            
             
PXL770 / Poxel SA           
          
            
             
camonsertib (RP-3500) / Repare Therap           
          
            
             
itanapraced (CHF-5074) / CereSpir           
          
            
             
zabedosertib (BAY 1834845) / Bayer           
          
            
             
vutiglabridin (HSG4112) / Glaceum           
          
            
             
ASN007 / Asana BioSci, Erasca, UT MD Anderson Cancer Center           
          
            
             
BI 706321 / Boehringer Ingelheim           
          
            
             
CBP501 / CanBas           
          
            
             
edecesertib (GS-5718) / Gilead           
          
            
             
ocadusertib (LY3871801) / Eli Lilly           
          
            
             
rineterkib (LTT462) / Novartis           
          
            
             
ASTX029 / Otsuka           
          
            
             
SF1126 / SignalRx           
          
            
             
ART0380 / Artios Pharma           
          
            
             
AZD7648 / AstraZeneca           
          
            
             
GFH312 / GenFleet Therap           
          
            
             
JTT-251 / Japan Tobacco           
          
            
             
SAR444656 / Sanofi           
          
            
             
SC0245 / Shijiazhuang Sagacity, Wuxi Biocity           
          
            
             
eclitasertib (DNL758) / Denali Therap, Sanofi           
          
            
             
gartisertib (M4344) / EMD Serono           
          
            
             
simurosertib (TAK-931) / Takeda, ZAI Lab           
          
            
             
ABBV-668 IR / AbbVie           
          
            
             
DCC-3116 / Ono Pharma           
          
            
             
DTRM-555 / Zhejiang DTRM Biopharma           
          
            
             
H-1337 / D. Western Therapeutics Institute           
          
            
             
HRS2398 / Jiangsu Hengrui Pharma           
          
            
             
LM-061 / LaNova Medicines Limited           
          
            
             
TQH3821 / Sino Biopharm           
          
            
             
leucine/metformin/sildenafil (NS-0200) / NuSirt           
          
            
             
tanzisertib (CC 930) / BMS           
          
            
             
AEG33773 / Pharmascience           
          
            
             
ASP1570 / Astellas           
          
            
             
ATRN-119 / Aprea           
          
            
             
C019199 / Fujian Haixi New Pharmaceutical           
          
            
            


12»